Top Stories
Company Results | Bank Mandiri (BMRI IJ/HOLD/Rp4,130/Target: Rp5,150)
BMRI’s 2Q26 earnings remained resilient, supported by lower provisions and strong non-interest income, although core profitability weakened. Despite a 19.2% yoy loan growth, NII lagged due to persistent NIM compression from tighter liquidity and intense pricing competition, prompting management to lower its NIM guidance. While asset quality remains healthy, a weaker funding mix, softer retail growth and policy-related uncertainty are likely to weigh on earnings. Maintain HOLD with an unchanged target price of Rp5,150.
Technical Analysis
Buana Lintas Lautan | BULL IJ
Trading Buy Range: We have a technical Buy at Rp434, and take profit at Rp470.
Bank Central Asia | BBCA IJ
Trading Buy Range: We have a technical Buy at Rp6,250, and take profit at Rp6,550.
Top Stories
Company Results | Bank Mandiri (BMRI IJ/HOLD/Rp4,130/Target: Rp5,150)
BMRI’s 2Q26 earnings remained resilient, supported by lower provisions and strong non-interest income, although core profitability weakened. Despite a 19.2% yoy loan growth, NII lagged due to persistent NIM compression from tighter liquidity and intense pricing competition, prompting management to lower its NIM guidance. While asset quality remains healthy, a weaker funding mix, softer retail growth and policy-related uncertainty are likely to weigh on earnings. Maintain HOLD with an unchanged target price of Rp5,150.
Technical Analysis
Buana Lintas Lautan | BULL IJ
Trading Buy Range: We have a technical Buy at Rp434, and take profit at Rp470.
Bank Central Asia | BBCA IJ
Trading Buy Range: We have a technical Buy at Rp6,250, and take profit at Rp6,550.
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/39d09b25-c4bd-4bfe-8aa7-49d7f37abfd5, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
